Chinese genomics company BGI has risen to prominence around the world but also has been subject to concerns about its gene sequencing and DNA collection practices. U.S. officials fear BGI's vast collection of global genomics data is not just intended for precision medicine but a strategic asset that could be used for the Chinese military or surveillance, including the development of a biotech-enabled "super soldier.
The U.S. House of Representatives on Monday passed a bill that aims to restrict business with China's WuXi AppTec , BGI and several other biotech companies on national security grounds.